Discover

CURX
Curanex Pharmaceuticals Inc
5.16
13 x 5.08
12 x 5.32
bid
ask
+
0.07
1.38%
13 @ 04:00 PM
5.00 -0.16 (3.10%)
Ytd-22.05%
1y-60.91%
5.08
day range
5.30
3.58
52 week range
14.12
Open5.08Prev Close5.09Low5.08High5.30Mkt Cap8.09M
Vol9.23KAvg Vol22.04KEPS-7.80P/EN/AForward P/EN/A
BetaN/AShort RatioN/AInst. OwnN/ADividendN/ADiv YieldN/A
Ex Div DateN/AEarningN/A50-d Avg4.73200-d Avg6.181yr Est0.00
Income Statement
Operating Expenses3.33M
Research and Development Expense2.59M
Selling, General and Administrative Expense731.84K
Operating Income-3.33M
Net Income-3.29M
Net Income Common Stock-3.29M
Net Income Common Stock (USD)-3.29M
Consolidated Income-3.29M
Earnings per Basic Share-2.40
Earnings per Basic Share (USD)-2.40
Earnings per Diluted Share-2.40
Earning Before Interest & Taxes (EBIT)-3.29M
Earning Before Interest & Taxes (USD)-3.29M
Weighted Average Shares1.42M
Weighted Average Shares Diluted1.42M
Balance Sheet
Cash and Equivalents2.94M
Cash and Equivalents (USD)2.94M
Current Assets4.79M
Property, Plant & Equipment Net280.94K
Total Assets5.07M
Debt Current94.41K
Total Debt276.36K
Current Liabilities104.31K
Debt Non-Current181.95K
Total Liabilities286.25K
Accumulated Retained Earnings (Deficit)-11.29M
Shareholders Equity4.79M
Shareholders Equity (USD)4.79M
Assets Non-Current280.94K
Total Debt (USD)276.36K
Liabilities Non-Current181.95K
Trade and Non-Trade Payables154.00
Cash Flow
Depreciation, Amortization & Accretion36.64K
Net Cash Flow / Change in Cash & Cash Equivalents-1.08M
Net Cash Flow from Operations-1.08M